CUE BIOPHARMA INC. -
1.7800
07-نوفمبر-24 15:59:28
15 متأخرة بدقائق
الأسهم
+0.1300
+7.88%
نطاق اليوم
1.5900 - 1.9000
ISIN
N/A
المصدر
NASDAQ
-
Cue Biopharma Reports First Quarter 2022 Financial Results
10 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Upcoming Oppenheimer 32nd Annual Healthcare Conference
10 مارس 2022 08:00:02 بحسب Nasdaq GlobeNewswire
-
02 مارس 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
15 فبراير 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
26 يناير 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast for Ongoing CUE-101 Clinical Trials
20 يناير 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
05 يناير 2022 08:00:02 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma Announces Appointment of Patricia Nasshorn as Chief Business Officer
15 ديسمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma to Present at JMP Securities Hematology and Oncology Summit
06 ديسمبر 2021 08:00:03 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Piper Sandler 33rd Annual Healthcare Conference
22 نوفمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
10 نوفمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
21 أكتوبر 2021 12:00:00 بحسب Nasdaq GlobeNewswire
-
04 أكتوبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
28 سبتمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma Granted U.S. Patents on Lead Clinical Program Novel Drug Product Candidate CUE-101
21 سبتمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
09 سبتمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire
-
17 أغسطس 2021 16:01:00 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
10 أغسطس 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
Cue Biopharma to Present Corporate Update at the Upcoming BTIG Virtual Biotechnology Conference
03 أغسطس 2021 08:01:12 بحسب Nasdaq GlobeNewswire